Polycomb segment myeloid malignancies
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
An unexpected revelation of cancer genome studies has been frequent abnormality in genes for factors that modify chromatin, underscored in this issue of Blood by reports from Score et al and Kroeze et al of inactivating mutations and chromosome loss in SUZ12, EED and JARID2 in myelodysplastic syndrome (MDS) and myeloproliferative disease (MPD).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ASXL1 inactivation is linked with up-regulation of the macrophage specifying transcription factor PU.1 and chronic myelomonocytic leukemia (45”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [45]
In the citing paper
“inactivating mutations or deletions of PRC2 components are frequent in leukemia (e.g. EZH2 or ASXL1 mutation or deletion)”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [45]
In the citing paper
“EZH2, inactivation is linked with up-regulation of the megakaryocyte specifying transcription factor FLI1, high platelet counts, and acute megakaryocytic leukemia”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [45]
Citations
Cites
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Nikoloski, G., Langemeijer, S. M. C., Kuiper, R. P., Knops, R., Massop, M., Tönnissen, E. R. L. T. M., van der Heijden, A., Scheele, T. N., Vandenberghe, P., de Witte, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.620 · Cited by 755
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
Goardon, N., Marchi, E., Atzberger, A., Quek, L., Schuh, A., Soneji, S., Woll, P., Mead, A., Alford, K. A., Rout, R., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.012 · Cited by 653
EZH2 mutational status predicts poor survival in myelofibrosis
Guglielmelli, P., Biamonte, F., Score, J., Hidalgo-Curtis, C., Cervantes, F., Maffioli, M., Fanelli, T., Ernst, T., Winkelman, N., Jones, A. V., et al. (2011) · Blood · doi:10.1182/blood-2011-06-363424 · Cited by 262
Kirstetter, P., Schuster, M. B., Bereshchenko, O., Moore, S., Dvinge, H., Kurz, E., Theilgaard-Mönch, K., Månsson, R., Pedersen, T. Å., Pabst, T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.008 · Cited by 251
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
Makishima, H., Jankowska, A. M., Tiu, R. V., Szpurka, H., Sugimoto, Y., Hu, Z., Saunthararajah, Y., Guinta, K., Keddache, M. A., Putnam, P., et al. (2010) · Leukemia · doi:10.1038/leu.2010.167 · Cited by 179
Self-citationScore, J., Hidalgo-Curtis, C., Jones, A. V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Ernst, T., Stegelmann, F., Döhner, K., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367243 · Cited by 177
Negrotto, S., Ng, K. P., Jankowska, A. M., Bodo, J., Gopalan, B., Guinta, K., Mulloy, J. C., Hsi, E., Maciejewski, J., & Saunthararajah, Y. (2012) · Leukemia · doi:10.1038/leu.2011.207 · Cited by 90
Self-citation
Cited by
Visconte, V., Makishima, H., Maciejewski, J. P., & Tiu, R. V. (2012) · Leukemia · doi:10.1038/leu.2012.130 · Cited by 124
Self-citationEvaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
Saunthararajah, Y., Sekeres, M. A., Advani, A. S., Mahfouz, R. Z., Durkin, L. M., Radivoyevitch, T., Englehaupt, R. K., Juersivich, J., Cooper, K., Husseinzadeh, H. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78789 · Cited by 91
“Responders were more likely than nonresponders to have needed pretreatment platelet transfusions, but had adequate neutrophil counts (32).”
Self-citationSaunthararajah, Y. (2013) · Hematology · doi:10.1182/asheducation-2013.1.511 · Cited by 79
Self-citationPellakuru, L. G., Iwata, T., Gürel, B., Schultz, D., Hicks, J. L., Bethel, C. R., Yegnasubramanian, S., & Marzo, A. M. D. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.021 · Cited by 62
“Although global levels of H3K27me3 have not been previously studied in the setting of EZH2 mutations in myelodysplastic syndrome, the presence of EZH2 mutations suggests that loss of H3K27me3, perhaps in specific loci, is important in this disease.(22) EZH2 mutations also occur in some diffuse large cell lymphomas, as…”
BackgroundConcise Review: Erythroid Versus Myeloid Lineage Commitment: Regulating the Master Regulators
Wolff, L., & Humeniuk, R. (2013) · Stem Cells · doi:10.1002/stem.1379 · Cited by 41
Metadata
- Authors
- Saunthararajah, Y., & Maciejewski, J.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2012-02-02
- Volume
- 119
- Issue
- 5
- Pages
- 1097-1098
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2019223103
- Semantic Scholar
- 3fbb627628ccf217c1c94c515fb8e5f4b82a30ea
- Cited by
- 12
- References
- 14
- Citations by year
- 2020: 1 · 2019: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA138858)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- Polycomb group genes, myeloid neoplasms, SUZ12, EED, JARID2, chromatin modification, loss-of-function mutations, chromosome loss, myelodysplastic syndrome, myeloproliferative neoplasms, cancer genome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycomb segment myeloid malignancies. https://app.cochat.ai/papers/10.1182/blood-2011-12-391268
- The paper
- Saunthararajah, Y., & Maciejewski, J. (2012). Polycomb segment myeloid malignancies. Blood. https://doi.org/10.1182/blood-2011-12-391268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.